Zorn Kevin C, Bernstein Andrew J, Gofrit Ofer N, Shikanov Sergey A, Mikhail Albert A, Song David H, Zagaja Gregory P, Shalhav Arieh L
Section of Urology, University of Chicago Pritzker School of Medicine, Chicago, Illinois 60614, USA.
J Endourol. 2008 May;22(5):1005-12. doi: 10.1089/end.2007.0381.
For men with high-volume or high-grade prostate cancer, wide excision of the ipsilateral neurovascular bundle is commonly performed. The concept of nerve reconstruction is intriguing as a feasible approach to preserve sexual function (SF). We sought to evaluate the functional, pathologic, and oncologic outcomes of men who underwent robot-assisted sural-nerve graft (SNG) interposition.
Between February 2003 and May 2007, 1175 consecutive men underwent robot-assisted laparoscopic radical prostatectomy (RLRP). Database analysis identified 27 men who had SNG: 4 bilateral (BL) and 23 unilateral (UL). SF was prospectively evaluated preoperatively and at 1, 3, 6, 12, and 24 months postoperatively using validated questionnaires. Positive surgical margins (PSMs), biochemical recurrence (BCR), and potency were evaluated.
Compared with RLRP patients without SNG, patients with SNG were younger (57.2 v 61.8 years, P=0.02), had a higher Gleason score (P=0.02), and had a higher clinical and pathologic stage (P<0.001 for both). Mean surgical time was significantly longer (349 v 195 min, P<0.001) in patients with SNG. With a mean follow-up of 26.1 months, 11 (47.8%) patients with UL-SNG and zero men with BL-SNG regained potency. No significant difference in SF was observed between UL nerve sparing and no SNG (56%) compared with UL nerve sparing with UL-SNG (P=0.44). Rates of return-to-baseline SF (RTB-SF) at 6, 12, and 24 months were 11%, 36% and 45% for UL-SNG, respectively, which were also comparable to UL nerve sparing only (P>0.05). No patient (0%) in the BL-SNG group ever achieved RTB-SF status at any time point. PSMs were observed in 37% (10/27) of all patients. BCR occurred in nine patients (33.3%), seven of whom had PSM (78%); treatment failure occurred within 6 months of surgery, necessitating androgen deprivation therapy.
Despite optimism regarding SNG, long-term functional outcomes have been disappointing, particularly for BL nerve interposition. UL-SNG functional outcomes do not appear to improve outcomes when compared with men with UL nerve preservation. With the greater risk of PSM and BCR in patients who are considered candidates for SNG, newer treatment modalities are needed to cure their disease while preserving SF.
对于患有大量或高级别前列腺癌的男性,通常会对同侧神经血管束进行广泛切除。神经重建的概念作为一种保留性功能(SF)的可行方法很有吸引力。我们试图评估接受机器人辅助腓肠神经移植(SNG)介入的男性的功能、病理和肿瘤学结果。
2003年2月至2007年5月期间,1175名连续男性接受了机器人辅助腹腔镜根治性前列腺切除术(RLRP)。数据库分析确定了27名接受SNG的男性:4名双侧(BL)和23名单侧(UL)。术前以及术后1、3、6、12和24个月使用经过验证的问卷对性功能进行前瞻性评估。评估阳性手术切缘(PSM)、生化复发(BCR)和性功能恢复情况。
与未接受SNG的RLRP患者相比,接受SNG的患者更年轻(57.2岁对61.8岁,P = 0.02),Gleason评分更高(P = 0.02),临床和病理分期也更高(两者均P < 0.001)。接受SNG的患者平均手术时间明显更长(349分钟对195分钟,P < 0.001)。平均随访26.1个月,11名(47.8%)单侧SNG患者和0名双侧SNG患者恢复了性功能。单侧保留神经与未进行SNG(56%)相比,与单侧SNG保留神经之间在性功能方面未观察到显著差异(P = 0.44)。单侧SNG在6、12和24个月时恢复到基线性功能(RTB - SF)的比例分别为11%、36%和45%,这也与仅单侧保留神经相当(P > 0.05)。双侧SNG组在任何时间点均无患者达到RTB - SF状态。所有患者中有37%(10/27)观察到PSM。9名患者(33.3%)发生BCR,其中7名有PSM(78%);治疗失败发生在手术后6个月内,需要进行雄激素剥夺治疗。
尽管对SNG持乐观态度,但长期功能结果令人失望,尤其是双侧神经介入。与单侧保留神经的男性相比,单侧SNG的功能结果似乎并未改善。对于被认为是SNG候选者的患者,PSM和BCR风险更高,需要更新的治疗方式来治愈疾病同时保留性功能。